AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33057739 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 106
Study 33057739 — intervention group
Group type: COMPARATOR
Intervention: Control group (Kegel exercises and bladder retraining)
Number of subjects: 106
Study 35476239 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic real-time feedback via daily computer-generated email to providers regarding their HCAHPS performance and peer comparison.
Number of subjects: 1110
Study 35476239 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dynamic feedback).
Number of subjects: 1110
Study 34238221 — intervention group
Group type: EXPERIMENTAL
Intervention: RITS toolbox
Number of subjects: 0
Study 32343631 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE–Helping Others through Purpose and Engagement (3-month volunteer placement)
Number of subjects: 74
Study 32343631 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 74
Study 35398397 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet- and mobile-based intervention (IMI) + treatment as usual (TAU)
Number of subjects: 210
Study 35398397 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 210
Study 34376508 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment in CombiRx (relapsing-remitting MS)
Number of subjects: 3810
Study 34376508 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment in ASCEND (secondary progressive MS)
Number of subjects: 3810
Study 34376508 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment in PROMISE (primary progressive MS)
Number of subjects: 3810
Study 34376508 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment in INFORMS (primary progressive MS)
Number of subjects: 3810
Study 34376508 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (per year increase)
Number of subjects: 3810
Study 33351814 — intervention group
Group type: EXPERIMENTAL
Intervention: Zung Self‐Assessment Scale for Anxiety (SAS)
Number of subjects: 1637
Study 33351814 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis
Number of subjects: 1637
Study 33351814 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis
Number of subjects: 1637
Study 35437129 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceiling nets and bed nets provided to 1,073 houses
Number of subjects: 2235
Study 35437129 — intervention group
Group type: COMPARATOR
Intervention: Bed nets only provided to 1,162 houses
Number of subjects: 2235
Study 33560104 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral lower extremity DUS surveillance on days 1, 3, and 7 and weekly during hospitalization (US)
Number of subjects: 1989
Study 33560104 — intervention group
Group type: COMPARATOR
Intervention: No surveillance (NoUS)
Number of subjects: 1989
Study 35450838 — intervention group
Group type: EXPERIMENTAL
Intervention: HBR+ patients
Number of subjects: 787
Study 35450838 — intervention group
Group type: COMPARATOR
Intervention: HBR- patients
Number of subjects: 787
Study 33358159 — intervention group
Group type: COMPARATOR
Intervention: 0% chopped grass hay
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% chopped grass hay
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% chopped grass hay
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: 0% to 5% hay
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% to 10% hay
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall digestibility
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestibility of starch, sugar, and fat
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestibility changes with age
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestive capacity
Number of subjects: 48
Study 33358159 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% chopped hay
Number of subjects: 48
Study 33958679 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS on the primary motor cortex (M1) for 20 min at 2 mA
Number of subjects: 18
Study 33958679 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS on the left dorsolateral prefrontal cortex (dlPFC) for 20 min at 2 mA
Number of subjects: 18
Study 33958679 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition (SHAM) for 20 min at 2 mA
Number of subjects: 18
Study 33369459 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Block (AB) - n=30, Superior laryngeal nerve block bilaterally and recurrent laryngeal nerve block transtracheally with Inj 2% Lignocaine
Number of subjects: 60
Study 33369459 — intervention group
Group type: COMPARATOR
Intervention: Airway Nebulization (AN) - n=30, Airway nebulized with 4% Lignocaine with ultrasonic nebulizer
Number of subjects: 60
Study 35548404 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation surgical nursing combined with PDCA circulation
Number of subjects: 80
Study 35548404 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing (Control)
Number of subjects: 80
Study 35548404 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 35548404 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 80
Study 33217877 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 60
Study 33217877 — intervention group
Group type: COMPARATOR
Intervention: Oral Jianweixiaoshi tablets
Number of subjects: 60
Study 34907021 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (25 mg/kg body weight per day) for 12 months
Number of subjects: 68
Study 34907021 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 68
Study 34271401 — intervention group
Group type: EXPERIMENTAL
Intervention: Horticultural therapy (HT)
Number of subjects: 59
Study 34271401 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 59
Study 34590981 — intervention group
Group type: EXPERIMENTAL
Intervention: W-shaped incision
Number of subjects: 61
Study 34590981 — intervention group
Group type: COMPARATOR
Intervention: Tear trough incision
Number of subjects: 61
Study 36055535 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral stimulation (BS)
Number of subjects: 61
Study 36055535 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral stimulation (US)
Number of subjects: 61
Study 36055535 — intervention group
Group type: COMPARATOR
Intervention: Sham (Control)
Number of subjects: 61
Study 33885203 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice daily)
Number of subjects: 8144
Study 33885203 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg twice daily)
Number of subjects: 8144
Study 33885203 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg once daily with taper)
Number of subjects: 8144
Study 33885203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8144
Study 34010807 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 36
Study 34010807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 34010807 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 36
Study 33099015 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention focusing on age-appropriate infant physical activation, healthy sleep and sedentary patterns, and response feeding, delivered through technology and phone counseling.
Number of subjects: 0
Study 33099015 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0
Study 36094451 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% CO2
Number of subjects: 12
Study 36094451 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% CO2
Number of subjects: 12
Study 36094451 — intervention group
Group type: COMPARATOR
Intervention: 0% CO2
Number of subjects: 12
Study 32703758 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0
Study 32703758 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaleidoscope usage
Number of subjects: 0
Study 32703758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 0
Study 32703758 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32703758 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative vomiting and nausea
Number of subjects: 0
Study 34776423 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (16 sessions of 60 minutes each over 8 weeks)
Number of subjects: 24
Study 36313402 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 42
Study 36313402 — intervention group
Group type: COMPARATOR
Intervention: Sham Laser (Control)
Number of subjects: 42
Study 32310273 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin therapy in PWH
Number of subjects: 135
Study 32310273 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin therapy in non-HIV participants
Number of subjects: 135
Study 35422024 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (1.25 mg tablets, titrated up to a maximum of 5 mg daily over 4-7 weeks)
Number of subjects: 1574
Study 35422024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical to bisoprolol)
Number of subjects: 1574
Study 33475735 — intervention group
Group type: COMPARATOR
Intervention: Control (standard transfusion strategy)
Number of subjects: 100
Study 32920205 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCy/tacrolimus/mycophenolate mofetil
Number of subjects: 0
Study 32920205 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus/methotrexate
Number of subjects: 0
Study 34847402 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based tailored intervention (three sessions with 27 tailored messages)
Number of subjects: 21
Study 32996893 — intervention group
Group type: EXPERIMENTAL
Intervention: MyDiabetesPlan (intervention group, n=111)
Number of subjects: 213
Study 32996893 — intervention group
Group type: COMPARATOR
Intervention: Control (static generic Diabetes Canada resources, control group, n=102)
Number of subjects: 213
Study 34275697 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalation therapy
Number of subjects: 55798
Study 34275697 — intervention group
Group type: COMPARATOR
Intervention: De-escalation to clopidogrel or low-dose prasugrel
Number of subjects: 55798
Study 34999696 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine identification of recurrent laryngeal nerve (Group A)
Number of subjects: 300
Study 34999696 — intervention group
Group type: COMPARATOR
Intervention: Non-identification of recurrent laryngeal nerve (Group B)
Number of subjects: 300
Study 32199717 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral inferior alveolar nerve block (BIANB)
Number of subjects: 51
Study 32199717 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol (control)
Number of subjects: 51
Study 33509043 — intervention group
Group type: EXPERIMENTAL
Intervention: del Nido cardioplegia
Number of subjects: 90
Study 33509043 — intervention group
Group type: COMPARATOR
Intervention: St. Thomas solution
Number of subjects: 90
Study 32350749 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (20 mg/kg/day)
Number of subjects: 35
Study 32350749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 35291966 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SCRT) combined with 6 cycles of capecitabine plus oxaliplatin (CAPOX) and Toripalimab (Consolidation arm)
Number of subjects: 130
Study 35291966 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 cycles of CAPOX and Toripalimab followed by SCRT and then 4 cycles of CAPOX and Toripalimab (Induction arm)
Number of subjects: 130
Study 32966832 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonodynamic therapy (SDT)
Number of subjects: 32
Study 35561480 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc gluconate (30 mg/day elemental zinc)
Number of subjects: 50
Study 33130281 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp pH
Number of subjects: 268
Study 33130281 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp lactates
Number of subjects: 268
Study 33130281 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe acidosis at birth (cord pH < 7.00)
Number of subjects: 268
Study 32888200 — intervention group
Group type: EXPERIMENTAL
Intervention: Immortalized F2 (IF2) population of Undaria pinnatifida
Number of subjects: 520
Study 35918587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oniria® (1.98 mg prolonged-release melatonin)
Number of subjects: 14
Study 35918587 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release tablets (IRT)
Number of subjects: 14
Study 33798305 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive scalp acupuncture
Number of subjects: 660
Study 33798305 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture
Number of subjects: 660
Study 33798305 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture plus cognitive training
Number of subjects: 660
Study 35200576 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 60
Study 35200576 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WT)
Number of subjects: 60
Study 34163127 — intervention group
Group type: EXPERIMENTAL
Intervention: ISVCZ 50ug/0.1 mL
Number of subjects: 60
Study 34163127 — intervention group
Group type: EXPERIMENTAL
Intervention: ISAMB 5ug/0.1 mL
Number of subjects: 60
Study 34163127 — intervention group
Group type: EXPERIMENTAL
Intervention: ISNTM 10ug/0.1 mL
Number of subjects: 60
Study 33210345 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation intervention
Number of subjects: 134
Study 33210345 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 134
Study 33017213 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative atrial fibrillation (pAF)
Number of subjects: 3023
Study 33017213 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm (control group)
Number of subjects: 3023
Study 34752681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with maintenance antidepressant medication (mADM)
Number of subjects: 282
Study 34752681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with discontinued maintenance antidepressant medication (mADM)
Number of subjects: 282
Study 34752681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with continued maintenance antidepressant medication (mADM)
Number of subjects: 282
Study 34752681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 282
Study 33743108 — intervention group
Group type: EXPERIMENTAL
Intervention: DArT method (dance-physiotherapy combined intervention)
Number of subjects: 38
Study 33743108 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 38
Study 33757137 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased nasal flow therapy (8-10 L/min)
Number of subjects: 212
Study 33757137 — intervention group
Group type: COMPARATOR
Intervention: Standard nasal flow therapy (5-7 L/min)
Number of subjects: 212
Study 33942801 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased TSH levels
Number of subjects: 726986
Study 33942801 — intervention group
Group type: EXPERIMENTAL
Intervention: FT3:FT4 ratio
Number of subjects: 726986
Study 33942801 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted FT4 and TPOAb
Number of subjects: 726986
Study 35590031 — intervention group
Group type: EXPERIMENTAL
Intervention: PROERD program (10 classes delivered by trained police officers)
Number of subjects: 4030
Study 35590031 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4030
Study 33857850 — intervention group
Group type: EXPERIMENTAL
Intervention: Fushen Granule (FSG)
Number of subjects: 42
Study 33857850 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (PRO)
Number of subjects: 42
Study 33857850 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 42
Study 33464760 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 60
Study 33464760 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 60
Study 33464760 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% ropivacaine
Number of subjects: 60
Study 86299308 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 standard marijuana cigarettes (2.8% Delta‐9‐THC)
Number of subjects: 5
Study 86299308 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 standard marijuana cigarettes (2.8% Delta‐9‐THC)
Number of subjects: 5
Study 33556551 — intervention group
Group type: EXPERIMENTAL
Intervention: Long head of biceps tenotomy
Number of subjects: 100
Study 33556551 — intervention group
Group type: COMPARATOR
Intervention: Suprapectoral long head of biceps tenodesis
Number of subjects: 100
Study 33556551 — intervention group
Group type: COMPARATOR
Intervention: Long head of biceps tenodesis
Number of subjects: 100
Study 33556551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study 32212817 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program including educational talk, demo video, experience sharing, pamphlet distribution, and text message reminders.
Number of subjects: 210
Study 32212817 — intervention group
Group type: COMPARATOR
Intervention: Educational talk alone (Control group).
Number of subjects: 210
Study 35030133 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative intravenous bolus dose of Dexmedetomidine
Number of subjects: 0
Study 35030133 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34247889 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardiac monitor (ICM)
Number of subjects: 334
Study 36100300 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-average continuity
Number of subjects: 173993
Study 36100300 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfect continuity
Number of subjects: 173993
Study 36100300 — intervention group
Group type: COMPARATOR
Intervention: Average continuity
Number of subjects: 173993
Study 34763475 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified dressing change
Number of subjects: 76
Study 34763475 — intervention group
Group type: COMPARATOR
Intervention: Traditional debridement and dressing change
Number of subjects: 76
Study 32628115 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive feedback
Number of subjects: 572
Study 32628115 — intervention group
Group type: COMPARATOR
Intervention: Standardized feedback
Number of subjects: 572
Study 32628115 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive feedback with immediate repetition
Number of subjects: 572
Study 32628115 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive feedback after a week
Number of subjects: 572
Study 32628115 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feedback forms
Number of subjects: 572
Study 36193094 — intervention group
Group type: EXPERIMENTAL
Intervention: L. crispatus G14‐5M (2 g twice daily for one month)
Number of subjects: 78
Study 36193094 — intervention group
Group type: EXPERIMENTAL
Intervention: L. helveticus M2‐09‐R02‐S146 (2 g twice daily for one month)
Number of subjects: 78
Study 36193094 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum CCFM8610 (2 g twice daily for one month)
Number of subjects: 78
Study 36193094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 36193094 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus strains (all three)
Number of subjects: 78
Study 36193094 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the Lactobacillus strains
Number of subjects: 78
Study 33341950 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information via a tablet computer plus 10 live health coaching sessions delivered virtually (intervention group; n=125)
Number of subjects: 250
Study 33341950 — intervention group
Group type: COMPARATOR
Intervention: Health information via a tablet only (control group; n=125)
Number of subjects: 250
Study 36447142 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) injected on embryo transfer day
Number of subjects: 100
Study 36447142 — intervention group
Group type: COMPARATOR
Intervention: Human chorionic gonadotropin (HCG) injected on embryo transfer day
Number of subjects: 100
Study 32498771 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention using 'Bear Blast' game module displayed on Samsung Gear Oculus VR headset
Number of subjects: 20
Study 32498771 — intervention group
Group type: COMPARATOR
Intervention: Tablet-based control intervention with comparable audio, visual, and tactile components
Number of subjects: 20
Study 32498771 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention
Number of subjects: 20
Study 35219908 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycosinate®
Number of subjects: 38
Study 35219908 — intervention group
Group type: COMPARATOR
Intervention: 5% Amorolfine
Number of subjects: 38
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC) (< 40 s)
Number of subjects: 389
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC) (1-2 min)
Number of subjects: 389
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Cord milking (CM) (4 times towards the neonate)
Number of subjects: 389
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Cord milking (CM)
Number of subjects: 389
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 389
Study 33184830 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 389
Study 35576073 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily for 3 months or until stone free
Number of subjects: 0